Representations Regarding. [**]. Isis represents and warrants to Genzyme as follows: (a) [**], Isis will Control all Know-How [**] that is [**] the manufacture, development or commercialization of Mipomersen, including the [**] Manufacturing Improvements and will have the sufficient legal and/or beneficial title and ownership or rights to grant the Product License to Genzyme under such Know-How and the grant of such license to Genzyme does not violate the terms of any Third Party Agreement or any other agreement Isis has with a Third Party [**]. (b) If [**], Isis will Control all Know-How [**] that is [**] the manufacture, development or commercialization of Mipomersen as of such date and will have [**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. the sufficient legal and/or beneficial title and ownership or rights to grant the Product License to Genzyme under such Know-How and the grant of such license to Genzyme does not violate the terms of any Third Party Agreement or any other agreement Isis has with a Third [**].
Appears in 2 contracts
Sources: License and Co Development Agreement (Genzyme Corp), License and Co Development Agreement (Isis Pharmaceuticals Inc)